NASDAQ
BCPC
Last Price
US $168.95
KEY FIGURES
MKT CAP
$5.5B
EPS
TTM
$4.90
PEG
TTM
2.10x
P/E
TTM
34.94x
P/S
TTM
5.30x
YIELD
0.56%
GROWTH
Revenue Y/Y
Profit margin
Current Ratio
Capital Returns
12.38%
Return on equity
ROIC: 11.14%
Valuation History
34.9X
Price to Earnings
EV/EBITDA: 20.7X
Cash flow
Profit margin
8.07%
(FY vs FY)
EBITDA Y/Y
9.43%
(FY vs FY)
Cash flow Y/Y
8.21%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $168.95
-49.94%
Default assumptions
EBITDA Multiple
Fair Value
Market $168.95
-69.59%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
Balchem Corp cash flow to debt ratio of 112.78% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.
Financial stability - Healthy cash flow growth.
Balchem Corp's free cash flow has increased 18.27% from $146.34M last year to $173.07M, signaling increasing performance
Financial stability - Healthy debt to equity ratio.
Balchem Corp's debt to equity ratio is 0.14, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial stability - Healthy debt to equity ratio development.
Balchem Corp's debt has decreased relative to shareholder equity from 0.18 last year to 0.14 today, signaling strengthened financials
Financial stability - Net debt/EBITDA.
Balchem Corp has a net debt to EBITDA ratio of 0.46x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
Balchem Corp's interest coverage ratio of 21.32 indicates that earnings with good margin can cover interest payments on company debt
Financial stability - Profit margin growth.
Balchem Corp's profit margin has increased (10.98%) in the last year from 13.47% to 14.95%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Balchem Corp's short-term assets of $365.61M exceed its short-term liabilities of $176.38M
Increasing performance - ROA.
Balchem Corp's return on assets of 9.33% is higher than the 5.00% threshold, indicating efficient asset utilization
Decreasing performance - Absolute return on equity.
Balchem Corp's return on equity of 12.38%, is lower than 15.00%, indicating bad performance
Increasing performance - Earnings quality.
Balchem Corp's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
Balchem Corp had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Balchem Corp has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Balchem Corp has a free cash flow yield of 3.15%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
Balchem Corp's yearly earnings has increased 20.53% since last year from $128.47M to $154.84M, signaling increasing performance
Increasing performance - Healthy revenue growth.
Balchem Corp's yearly revenue has increased 8.75% since last year from $953.68M to $1.04G, signaling increasing performance
Increasing performance - ROIC.
ROIC 11.14% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
Increasing performance - 3-year revenue CAGR.
Balchem Corp's 3-year revenue CAGR of 3.25% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Balchem Corp had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Balchem Corp had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Balchem Corp is overvalued relative to its fair value price of 84.58 based on Discounted Cash Flow model
Overvalued - Earnings yield.
Balchem Corp has an earnings yield of 2.86%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings
Overvalued - EBITDA valuation.
Balchem Corp is overvalued relative to its fair value price of 51.37 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Balchem Corp has an EV/EBITDA ratio of 20.74x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings
Overvalued - PEG ratio value.
Balchem Corp has a PEG-ratio over 1 which is considered overvalued
Undervalued - P/B ratio.
Balchem Corp has a price-to-book ratio of 4.30x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Balchem Corp has a price-to-sales ratio of 5.20x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue